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INTRODUCTION
Nigeria is the most populous black nation in the 
1 
world with a population of 160 million. As is the 
trend in most developing nations of the world, the 
burden of non-communicable diseases such as 
hypertension, diabetes mellitus and chronic kidney 
disease (CKD) is on the increase worldwide. More 
than 50million people are said to have CKD with 
over a million persons having end-stage renal 
disease (ESRD) requiring one form of renal 
2, 3
replacement Therapy (RRT).
In Nigeria, CKD said to account for 8-10% of 
4,5
hospital admissions,  with a prevalence ranging 
between 1.6 and 12.4%. {6}The number of 
Nigerians who have ESRD is not known due to 
non-existence of a national renal registry. Problems 
with capturing and systematic ways of reporting 
cases of ESRD have contributed to this among 
others.The common causes of CKD in Nigeria 
include;chronic glomerulonephritis (CGN) and 
hypertension in adults while obstructive uropathy 
from congenital causessuch as posterior urethral 
valves and CGN remain the leading causes in 
6children.
Data from most sub-Saharan African (SSA) 
countries (including Nigeria)show that most 
patients with ESRD have no access to adequate 
care when compared with their counterparts in the 
7developed world.
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ABSTRACT
The burden of chronic kidney disease (CKD) is increasing in most developing countries such as Nigeria. 
There are over a million persons with end-stage kidney disease (ESRD) requiring renal replacement 
therapy (RRT) around the world. The cost of providing care for patients with ESRD is colossal; and data 
from most renal centres in Nigeria show that majority of patients are unable to afford the cost of care 
resulting in a high mortality among ESRD patients. Also, there is no organized funding mechanism for RRT 
in Nigeria. We highlight some of the challenges limiting access to care for ESRD patients in Nigeria and 
propose some recommendations on how to change this paradigm.
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Renal replacement therapyencompasses all life-
supporting treatments for ESRD patients. These 
include; hemodialysis (HD), peritoneal dialysis 
(PD) and renal transplantation. In most developed 
economies of the world, renal replacement therapy 
is funded by governments and insurance schemes. 
However, in Nigeria, these therapies are far beyond 
the reach of majority of ESRD patients who need 
them due to their prohibitive costs. Also, there is 
presently no organized funding mechanism for RRT 
in Nigeria; these have left the burden of ESRD care 
to the patients and their relations in the majority of 
7
cases.
CURRENT STATE OF CARE OF ESRD 
PATIENTS IN NIGERIA
Renal replacement therapy has been in existence in 
Nigeria for over three decades; with centres such as 
Obafemi Awolowo University Teaching Hospital 
(OAUTH),Ile-Ife and University College Hospital 
(UCH), Ibadan being the pioneers. The 
8-11mainmodality of RRT available is HD.  Currently, 
 
there are over 30 Nigerian Federal Government 
health facilities with several privately owned health 
institutions providing haemodialysis services 
across Nigeria.These centres are grossly inadequate 
for the teaming population of ESRD patients in the 
country. Also, the majority of the HD centres are 
located within cities limiting access to care for the 
8rural Nigerian with ESRD.  The cost for HD varies 
widely across Nigeria between the public and 
private facilities;  with cost per session of HD 
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ranging from between 10 and 40 thousand NGN 
(62 and 250 USD).  In addition, the absence of 
government funding or subsidy and health 
insurance to cover the relatively high cost of HD 
has limited its availability. A review of HD across 
the country showed that most ESRD patients 
cannot sustain 3 times per week HD; and by the end 
of a three month period, majority(over 90%) had 
 7, 12,
stopped HD due to lack of funds.
Since the inception of RRT in Nigeria, peritoneal 
dialysis (PD) has largely not been available. A 
review of RRT modalities of treatment over a 19 
year period in a centre showed that CAPD 
13constituted only 1.2% of RRT  which shows its 
very low rate of use in the country. The absence of a 
PD fluid and consumables manufacturing plant in 
the country has led to the importation of PD fluids 
and consumables making PD care expensive and so 
it is largely beyond the reach of ESRD patients 
13where available.
Issues of infection (peritonitis) in the past have also 
discouraged the wide use of this modality of 
14,15RRT.  Presently, there is very little training and 
experience on PD among the staff of the renal units 
in Nigeria since this modality of therapy is hardly 
used in the country.
Renal transplantation has been adjudged as the best 
form of RRT; and in the long-term the cheapest 
form of RRT worldwide. However, it accounts for 
13
less than 1% of RRT in Nigeria.  In Nigeria renal 
transplantation is done by a number of public and 
private institutions including: OAUTH, UCH, 
Lagos University Teaching Hospital (LUTH), 
University of Maiduguri Teaching Hospital 
(UMTH), Aminu Kano Teaching Hospital (AKTH) 
and St. Nicholas Hospital, Lagos. Of these 
institutions, St. Nicholas hospital has the most 
experience of over a decade, with an average of 10 
renal transplants per year. The main challenge with 
this modality of RRT in Nigeria is the cost of the 
surgery and immunosuppressive drugs which 
arefar beyond the reach of majority of ESRD 
13,16patients.  In Nigeria, live-donor kidney 
transplant costs between 7 and 10 million NGN 
(33,000.076,000.0 USD) excluding costs of 
immunosuppressive agents. {8}Another challenge 
to successful renal transplant is there are few 
skilled/ trained transplant surgeons and 
nephrologists with the requisite expertise and 
17 
experience in pre and post- renal transplant care.
In addition, majority of the institutions that started 
the renal transplant programme in Nigeria had to 
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stop because they lacked necessary equipmentsand 
p e r s o n n e l  ( i n c l u d i n g  t r a i n e d  r e n a l  
histopathologists) for monitoring and ensuring the 
safety of the allograft.
RECOMMENDATIONS FOR IMPROVED 
CARE FOR ESRD PATIENTS IN NIGERIA
Resources available for RRT vary substantially 
between countries; with the developed nations of 
the world like USA spending over 12 billion USD in 
7 
1998 alone on medicare spending for ESRD.  while 
the ESRD patients in most developing countries in 
Sub-saharan Africa including Nigeria are left to pay 
for their care out of pocket with little or no 
government support or subsidy. 
In the light of the numerous challenges that bedevil 
ESRD patients in Nigeria, we put forward the 
following recommendations:
1.   Establishment of a National Renal Registry.
Recently there have been cries from different 
parts of sub-Saharan Africa; Nigeria inclusive 
on the need to have a systematic and organized 
way of capturing and reporting data on CKD 
6,10,18,19
patients requiring RRT. . Comprehensive 
data from a renal registry will form the basis for 
planning and lobbying government to 
formulate policies that will change renal care in 
Nigeria. The effort by the Nigerian association 
of nephrology (NAN) to establish a functional 
renal registry has not yielded much result. The 
much talk or write up for government 
involvement in renal care will not sell until facts 
and figures are presented to government from 
data systematically collected all over the 
country.
2.   The enactment of Nigerian Renal Care Law.
The high mortality reported among ESRD 
7,12patients in Nigeria,  poverty vis-à-vis the high 
cost of RRT in Nigeria makes it emergent for the 
enactment of the Renal Care Law. it was the 
realization of the fact that the cost of ESRD was 
more than the individual patients and their 
families could bear that led the United States 
(US) congress to pass the law on ESRD in 1973; 
which was later followed by the US organ 
20,21 transplant act. The renal care bill is awaiting 
its passage into law. NAN and other concerned 
stake holders have made representations to the 
Nigerian national assembly on the importance 
of the passage of this bill. The passage of this 
bill into law will change the paradigm of care of 
ESRD patients in Nigeria.
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3. The incorporation of renal care into the national 
health insurance scheme (NHIS).
There is no doubt that the NHIS has impacted 
the health of the average Nigerian. However, 
the current level of contributory funding by the 
participating individual remains low. As the 
NHIS  moves  to  i t s  nex t  l eve l  o f  
implementation, it will be important to consider 
revision of the contributions made by the 
participants upwards with a view towards 
including ESRD care among the services to be 
covered by the NHIS. This will guarantee 
sustainable care for ESRD patients in Nigeria.
4. Provision of subsidy for ESRD care by 
Government of Nigeria (GoN).
As all the strategies mentioned above will 
require legislation and time to come to fruition; 
it will be needful to put in place short-term 
measure(s) to cushion the financial burden 
being faced by ESRD patients and their 
families while awaiting implementation of the 
above recommendations. One of such measures 
will be the provision of subsidy by the federal 
or state governments. This subsidy should be in 
the form of procurement of dialysis 
consumables in large quantities and subsequent 
distribution to the dialysis centres (including 
private centres if possible). Although, a good 
number of the ESRD patients may still not be 
able to afford the care. Many state governments 
and philanthropists have already adopted this 
strategy. Also, the GoN during the era of 
petroleum tax fund (PTF) supplied some HD 
consumables to some renal centres in the 
country; these centres provided HD services at 
much reduced cost and in certain instances at no 
cost. This strategy will go a long way to bring 
down the cost per session of HD to affordable 
levels.
In conclusion, the prevalence of ESRD reported to 
be on the rise in Nigeria. The current state of care of 
ESRD in Nigeria is dismal; with majority of 
patients being unable to sustain maintenance HD 
beyond 3 months resulting in a high mortality. PD is 
unavailable in most centres currently in Nigeria; 
while renal transplantation is out of the reach for 
most of the ESRD patients except for a privileged 
few who get assistance from willing state 
governments or corporate organisations. To change 
the paradigm of care of ESRD patients in Nigeria, 
drastic steps will need to be taken to put in place a 
renal registry, the long awaited renal care bill 
should be passed into law by the Nigerian national 
assembly, the NHIS should be upgraded to cover 
care for ESRD patients and finally, the 
procurements of HD consumables by federal and 
state governments or philanthropists which should 
be donated to HD centres across the country will 
reduce the cost of HD substantially and reduce the 
financial burden on ESRD patients in Nigeria.  
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